[News Brief] Legend Biotech to Present LB2501 Data at EHA 2026
Legend Biotech Corporation has announced that it will present preliminary Phase 1 clinical data for its investigational LB2501 therapy during…
Global PR
[News Brief] Zylox-Tonbridge Named Honoured Company in Extel Survey
Zylox-Tonbridge Medical Technology Co., Ltd has been named a Most Honoured Company in Extel’s 16th Asia Executive Team Survey, with…
[News Brief] CordenPharma Agrees to Acquire AmbioPharm
CordenPharma has entered into an agreement to acquire AmbioPharm, a US-headquartered contract development and manufacturing organisation (CDMO), to expand its…
[News Brief] Philips and ASCI Sign Cardiovascular Imaging MOU
Philips and the Asian Society of Cardiovascular Imaging (ASCI) have signed a three-year Memorandum of Understanding during the 19th ASCI…
[News Brief] Australia Approves OncoSil™ Device for Pancreatic Cancer
Australia’s Therapeutic Goods Administration (TGA) has approved the OncoSil™ medical device for use in patients with locally advanced pancreatic cancer.…
[News Brief] Medtec China 2026 Scheduled for September in Shanghai
Medtec China 2026, a medical device manufacturing trade exhibition, will be held at the Shanghai New International Expo Centre, bringing…
[News Brief] HKSH Named Siemens Healthineers Photon-Counting CT Site
HKSH Medical Group and Siemens Healthineers have signed a collaboration agreement designating HKSH as the first Photon-Counting Computed Tomography Simulator…
[News Brief] Datar Cancer Genetics Secures US FDA Clearance for Assay
Datar Cancer Genetics has received US Food and Drug Administration clearance for CellDx-Tissue, a tissue-based comprehensive genomic profiling assay designed…
[News Brief] Zylox-Tonbridge to Acquire Equity Interest in Optimed
Zylox-Tonbridge has entered into a definitive agreement to acquire a Germany-based medical technology company, Optimed Medizinische Instrumente GmbH, in multiple…
[News Brief] AstraZeneca Enters Licensing Agreement with CSPC Pharmaceuticals
AstraZeneca has entered into a strategic collaboration with CSPC Pharmaceutical Group to obtain ex-China rights to a weight management portfolio…